MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
116 hedge funds and large institutions have $246M invested in Merrimack Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 41 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
59% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $2.47M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
116
Holding in Top 10
–
Calls
$1.01M
Puts
$2.47M
Top Buyers
| 1 | +$35.6M | |
| 2 | +$3.89M | |
| 3 | +$3.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.3M |
| 5 |
AWCI
Alpine Woods Capital Investors
Purchase,
New York
|
+$2.24M |
Top Sellers
| 1 | -$37M | |
| 2 | -$37M | |
| 3 | -$20.4M | |
| 4 |
ICP
Indus Capital Partners
New York
|
-$4.28M |
| 5 |
LIM
Lagoda Investment Management
New York
|
-$2.3M |